Opus Genetics (IRD) Tax Provisions (2022 - 2023)
Opus Genetics (IRD) reported Tax Provisions of -$2000.0 for Q4 2023, down 100.63% year-over-year from $315000.0 in Q4 2022, and down 114.29% quarter-over-quarter from $14000.0 in Q3 2023.
Opus Genetics (IRD) Tax Provisions (2022 - 2023) Analysis & Trends
Opus Genetics (IRD) has 2 years of Tax Provisions data on file, last reported at -$2000.0 in Q4 2023.
- Tax Provisions for Q4 2023 came in at -$2000.0, down 100.63% year-over-year; the trailing twelve-month figure through Sep 2024 was -$2000.0 (down 100.61% YoY), and the FY2023 annual result was $12000.0, down 96.19% from the prior year.
- Tax Provisions fell to -$2000.0 in Q4 2023 per IRD's latest filing, from $14000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $315000.0 in Q4 2022 and troughed at -$2000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Opus Genetics | 355.39 Mn | 295.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Dec 31, 2022 | 315,000.00 |